Robert & Lynda Altman Family Foundation
- Assets
- $218.8m
- Revenue
- -$2.0m
- Investments
- $185.1m
- Employees
- 0
- Location
- Baltimore, MD
- Founding
- Data as of
- 12/2022
- EIN
- 87-3339629
Organization Overview
Robert & Lynda Altman Family Foundation is located in Baltimore, MD. According to its NTEE Classification (T22) the organization is classified as: Private Independent Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Robert & Lynda Altman Family Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
James Altman Trustee | 0.25 | $0 | |
Jessica Altman Trustee | 0.25 | $0 | |
Lynda Carter Altman Trustee | 0.25 | $0 | |
John Emerson Disinterested Trustee | 0.25 | $0 | |
Marianne Schmitt Hellauer Disinterested Trustee | 0.25 | $0 | |
James Altman Trustee | 0.25 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Pershing Advisor Solutions Llc | 12/30/22 | $148,162 |
Brown Brothers Harriman | 12/30/22 | $66,948 |
Pershing Advisor Solutions Llc | 12/30/22 | $148,162 |
Brown Brothers Harriman | 12/30/22 | $66,948 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $0 |
| Interest on Savings | $0 |
| Dividends & Interest | $3,237,308 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | -$5,254,046 |
| Capital Gain Net Income | $0 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | -$4,357 |
| Total Revenue | -$2,021,095 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $72,981 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $0 |
| Printing and publications | $0 |
| Other expenses | $143,566 |
| Total operating and administrative expenses | $445,623 |
| Contributions, gifts, grants paid | $4,525,684 |
| Total expenses and disbursements | $4,971,307 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $33,636,502 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $71,752,858 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $218,767,271 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
Grants Awarded
Over the last fiscal year, Robert & Lynda Altman Family Foundation has awarded $9,051,368 in support to 5 organizations.
| Grant Recipient | Amount |
|---|---|
TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION PURPOSE: GENERAL PURPOSE | $4,325,684 |
SMITHSONIAN INSTITUTION PURPOSE: GENERAL PURPOSE | $200,000 |
SMITHSONIAN INSTITUTION PURPOSE: GENERAL PURPOSE | $200,000 |
TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION PURPOSE: ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE DIAGNOSTIC RESEARCH PROJECT, IS TO BE CONDUCTED BY TGEN TO DEVELOP TWO DIAGNOSTIC TESTS. THE FIRST DIAGNOSTIC RESEARCH PROJECT IS TO IDENTIFY THE MOST SENSITIVE TEST FOR THE TRANSITION FROM MPN TO SAML. THE SECOND DIAGNOSTIC RESEARCH PROJECT IS TO DEVELOP AND DEPLOY AN ULTRA-RAPID WHOLE GENOMIC SEQUENCING TEST TO IDENTIFY DRUG TREATMENT OPTIONS FOR PATIENTS WHO HAVE TRANSITIONED FROM MPN TO SAML. | $3,070,884 |
TRANSLATIONAL GENOMICS RESEARCH INSTITUTE FOUNDATION PURPOSE: ESTABLISHMENT OF THE ROBERT & LYNDA CARTER ALTMAN FAMILY RESEARCH FUND WITH TGEN AND ITS AFFILIATE, CITY OF HOPE, TO FACILITATE RESEARCH EFFORTS IN TWO COMPLEMENTARY AREAS SPECIFICALLY DESIGNED FOR RAPID IMPROVEMENT OF PATIENT OUTCOMES WHO SUFFER FROM MPN/SAML. ONE RESEARCH PROJECT, THE THERAPEUTIC RESEARCH PROJECT, TO BE CONDUCTED BY THE CITY OF HOPE WILL COMPREHENSIVELY TEST AND SCALE UP THE MANUFACTURE OF THE DRUG DENOMINATED AS MIR-142. THIS "MIMETIC" DRUG SIMULATES (REPLACES) THE ACTION OF A NORMAL SIGNAL THAT IS MISSING IN MPN/SAML PATIENTS. | $1,254,800 |